ArticleMultiple sclerosis and related disorders2022

Humoral efficacy of the third SARS-CoV-2 vaccine dose in Multiple Sclerosis subjects undergoing different disease-modifying therapies.

Giorgia Teresa Maniscalco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.